Despite efforts by states to introduce legislation to make healthcare pricing information more accessible for consumers, most states still receive an F grade, according to the third annual Report Card on State Price Transparency Laws.
Despite efforts by states to introduce legislation to make healthcare pricing information more accessible for consumers, most states still receive an F grade, according to the third annual Report Card on State Price Transparency Laws from Catalyst for Payment Reform (CPR) and Health Care Incentives Improvement Institute (HCI3).
The report is based on legislation passed in 2014, and since then many states have introduced legislation that may still pass. However, since last year’s report, based on 2013 legislation, few states have received grade changes. A full 45 states received an F in this year’s report.
“Given how little progress there has been with state laws, it’s important to understand the tenuous legal arguments used by some in the industry to keep price information inaccessible to the public,” Francois de Brantes, HCI3 executive director, said in a statement. “Very few of the commonly used arguments have merit.”
Only 3 states received grade changes: Colorado, Massachusetts, and New Hampshire. Last year Colorado had received a C since it was on the verge of releasing a public price transparency website. This year, the public website was up and running, but since it is still in a nascent stage and consumers can only search for maternity care and hip and knee replacements, Colorado received a B grade.
In New Hampshire, the addition of a new website, NH HealthCost, jumped the state from an F grade in the last report to an A this year. The site accounts for both insured and uninsured patients and provides great details in consumer-friendly terms, making it a model for other states looking to develop price information, according to the report.
Lastly, Massachusetts, which has traditionally received high honors in past report cards, received an F this year. When new legislation placed the responsibility of transparency on health plans, the government website, MyHealthCareOptions, was shut down. The loss of the government site meant entire populations of consumers, including the uninsured were unable to find price information.
“While we expect the private sector to lead advances in price transparency, there is an undeniable role for states—and we need them to step up,” said Suzanne Delbanco, executive director of CPR.
POSITIVE Trial Update on Patients With Breast Cancer Attempting Pregnancy
December 8th 2023At last year’s San Antonio Breast Cancer Symposium, POSITIVE trial primary outcome data were presented on breast cancer–free interval, with women who paused endocrine therapy to attempt pregnancy having a similarly small rate of recurrence vs external controls from the SOFT and TEXT trials: 8.9% vs 9.2%.
Read More
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Prediction Model Identified Risk Factors for ED Visits in Patients With Lung Cancer
December 7th 2023A risk prediction model that was based on machine learning could help to make resource utilization more efficient by correctly predicting emergency department (ED) visits in patients with lung cancer.
Read More